Researcher Tools & Resources

Your research is critical to creating a brighter future for people with Riboflavin Transporter Deficiency.

We are a world-leading source of support for research into the fundamental understanding of Riboflavin Transporter Deficiency (RTD), diagnosis and treatments.  For researchers and scientists carrying-out research we provide:

Research Funding

We offer one- and two-year grants for scientists at different stages of their career. This seed funding is essential for many scientists to obtain preliminary data required to compete for more competitive grants at other organizations, such as the National Institutes of Health.  We encourage all investigators at every professional level to submit their best ideas. There are no geographical limitations to this funding.  For more information please visit our Research Grant Program. 

Scientific Resources

We offer access to a variety of scientific resources, including:

• Largest active registry of individuals with Riboflavin Transporter Deficiency.
• Human SLC52 Gene Variants Database

Connections and Collaboration

Cure RTD provides opportunities for connection and collaboration among researchers and the RTD community.  We do so by:

• Offering access to our international Scientific & Medical Advisory Board, which comprises world-renowned clinicians and scientists who are leading experts in Riboflavin Transporter Deficiency (RTD).
• Connecting you to other scientists to obtain resources – such as biological samples – that you might need for your research.
• Announcing study participation opportunities to our RTD community to help scientists reach their enrollment goals.
• Cure RTD also acts as a convener, organizer and supporter of state-of-the-art research meetings such as the RTD International Scientific & Medical Conference, in order to facilitate and maintain international collaboration among scientists in the field.

Research Advocates

We advocate with members of Congress on behalf of the research community for adequate funding of the National Institutes of Health and other government institutions where researchers usually apply for grants. We also advocate at the National Institutes of Health for grant mechanisms that will benefit RTD research.

Together we can help achieve victory over Riboflavin Transporter Deficiency